A detailed history of Procyon Advisors, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 10,981 shares of VCYT stock, worth $477,783. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,981
Previous 15,087 27.22%
Holding current value
$477,783
Previous $326,000 14.42%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$21.0 - $35.25 $86,226 - $144,736
-4,106 Reduced 27.22%
10,981 $373,000
Q2 2024

Aug 02, 2024

BUY
$18.86 - $23.55 $284,540 - $355,298
15,087 New
15,087 $326,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.11B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.